ScholarIQanswers from OpenAlex & ORCID
Xavier Calvet
ResearcherPublications, citations & collaboration network
Xavier Calvet is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Xavier Calvet have?
ScholarIQindexed works
Xavier Calvet has 638 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Xavier Calvet have?
ScholarIQcitation count
Xavier Calvet has 16,356 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Xavier Calvet?
ScholarIQh-index
Xavier Calvet has an h-index of 71 in OpenAlex.
What is the i10-index of Xavier Calvet?
ScholarIQi10-index
Xavier Calvet has an i10-index of 250 in OpenAlex.
What is the ORCID of Xavier Calvet?
ScholarIQorcid
The ORCID for Xavier Calvet is on the source record.
What is the OpenAlex record for Xavier Calvet?
ScholarIQopenalex
The OpenAlex for Xavier Calvet is on the source record.
What are the most-cited papers on Xavier Calvet?
ScholarIQmost cited works
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
Alan Barkun, Majid A. Almadi, Ernst J. Kuipers, Loren Laine, Joseph J.�Y. Sung, Frances Tse, Grigorios I. Leontiadis, Neena S. Abraham, Xavier Calvet, Francis K.L. Chan, James D. Douketis, Robert Enns, Ian M. Gralnek, Vipul Jairath, Dennis M. Jensen, James Lau, Gregory Y.H. Lip, Romaric Loffroy, Fauze Maluf‐Filho, Andrew C. Meltzer, D. Nageshwar Reddy, John R. Saltzman, John K. Marshall, Marc Bardou
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Bruce E. Sands, Peter M. Irving, Timothy Hoops, James Izanec, Long-Long Gao, Christopher Gasink, Andrew Greenspan, Matthieu Allez, Silvio Danese, Stephen B. Hanauer, Vipul Jairath, Tanja Kuehbacher, James D. Lewis, Edward V. Loftus, Emese Mihály, Remo Panaccione, Ellen Scherl, О. Б. Щукина, William J. Sandborn, Anita Afzali, Lilia Aitova, Xavier Aldeguer i Mante, Matthieu Allez, I Altorjay, Federico Argüelles‐Arias, Alessandro Armuzzi, Monika Augustyn, Mauro Bafutto, Jésus Barrio, Jakob Begun, Clint Behrend, Geert Bezemer, Guillaume Bonnaud, Marija Branković, Ik Jang Byung, Xavier Calvet, Karen A. Chachu, Júlio Maria Fonseca Chebli, Jae Hee Cheon, Halina Cichoż‐Lach, Larry Clark, Fraser Cummings, Kunal Dalal, Silvio Danese, Nanne K.H. de Boer, Maria de Lourdes Abreu Ferrari, Étienne Désilets, Predrag Dugalić, George Duvall, Olga Fedorishina, Rafał Filip, Cristina Flores, Ronald Fogel, James Fon, Michael Frankel, Keith Friedenberg, Walter Fries, Vassileva Galina, Piotr Gietka, Rishi Goel, Peter Hasselblatt, Hans Herfarth, László Herszényi, Pieter Hindryckx, Frank Hoentjen, Carmen Horjus Talabur Horje, Satish Iduru, Peter M. Irving, Robert J. Isfort, Vipul Jairath, Michael Jones, Dilara Kalimullina, Jeffry Katz, Manreet Kaur, Sunil K Khurana, Joo Sung Kim, Young‐Ho Kim, D Kleczkowski, Slavko Knezevic, Aaron Knoll, Louis Y Korman, Iskren Kotzev, Andrey Kulyapin, Kang‐Moon Lee, Desirée Leemreis, Jarosław Leszczyszyn, Jimmy K. Limdi, Jack J. Lissauer, Edward V. Loftus, Ewa Małecka‐Panas, John K. Marshall, Emese Mihály, Lukáš Milan, Giovanni Monteleone, Aleksandar Nagorni, Danuta Owczarek, Nichole Palekar, Remo Panaccione, Young Soo Park, Sang Hyoung Park
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
Carme Loras, Javier P. Gisbert, Miguel Mínguez, Olga Merino, Luís Bujanda, Cristina Morales Saro, Eugeni Domènech, Jésus Barrio, Montserrat Andreu, Íngrid Ordás, LN Vida, Guillermo Bastida, Ferrán Gónzalez‐Huix, Marta Piqueras, Daniel Ginard, Xavier Calvet, A Gutiérrez, Á Abad, M. Torres, Julián Panés, María Chaparro, Isabel Pascual, Mónica Rodríguez‐Carballeira, Fernando Fernández‐Bañares, J.M. Viver, María Esteve, for the REPENTINA study, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group
Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
for the REPENTINA study, GETECCU group (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa), Carme Loras, Cristina Morales Saro, Ferrán Gónzalez‐Huix, Miguel Mínguez, Olga Merino, Javier P. Gisbert, Jésus Barrio, Antonio Bernal, Ana Gutiérrez, Marta Piqueras, Xavier Calvet, Montserrat Andreu, Águeda Abad, Daniel Ginard, Luís Bujanda, Julián Panés, Miquel Torres, Fernando Fernández‐Bañares, Josep Maria Viver, María Esteve